In mouse study, stem cells migrated to proper locations in fetal brain and body, differentiated into cells that produce crucial missing protein.
Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UC San Francisco researchers, who showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.
UCSF Perinatolgist and Medical Geneticist Teresa Sparks, M.D., Assistant Professor, Ob/Gyn, Reproductive Sciences, recently received the Dru Carlson Memorial Award for Best Research in Ultrasound and Genetics from the Society for Maternal-Fetal Medicine (SMFM) at their 40th Annual Meeting in Grapevine, TX.
Rachel Shulman, MD et al. were awarded the 2020 Manuscript of the Year award by the American Journal of Perinatology, for their publication Fetal Congenital Pulmonary Airway Malformation: The Role of an Objective Measurement of Cardiomediastinal Shift.
Hilton San Francisco Financial District
750 Kearny St., San Francisco, CA 94108
Interactive and case-based educational symposium:
• Advances in fetal diagnosis
• Innovative therapeutic strategies
For more information, email [email protected]
*Concurrent with Western Society of Pediatric Cardiology Conference 2020